Abstract
We used a recently described molecular cytogenetic method, spectral karyotyping (SKY), to analyze metaphase chromosomes from 30 pediatric patients with acute lymphoblastic leukemia (ALL). This group included 20 patients whose leukemic blast cells lacked chromosomal abnormalities detected by conventional cytogenetics and 10 patients whose blast cells had multiple chromosomal abnormalities that could not be completely identified by G-banding analysis. In two of the 20 patients (10%) with apparently normal karyotypes, SKY identified three cryptic translocations: a t(7;8)(q34–35;q24.1) in one patient and a t(13;17)(q22;q21) and a der(19)t(17;19)(q22;p13) in another. Fluorescence in situ hybridization using subtelomeric probes proved the latter translocation to be a t(17;19). SKY analysis was also successful in defining the nature of the chromosomal abnormalities in four of the 10 patients with marker and derivative chromosomes. The identified abnormalities in the latter group included three novel translocations: a der(X)t(X;5)(p11.4;q31), a der(21)t(X;21)(p11.4;p11.2) and a t(X;9)(p11.4;p13). The presence of the t(X;9) was suggested by conventional cytogenetics. The application of fluorescence in situ hybridization using chromosome-specific painting probes and locus-specific probes complemented the SKY analysis by confirming the nature of the chromosome rearrangements defined by SKY and by identifying the amplification of the AML1/CBFA2 gene in one patient with a duplicated 21q. Our study demonstrates the utility of SKY in identifying novel translocations and in refining the identity of chromosomal abnormalities in leukemias.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Heim S, Mitelman F . Cancer Cytogenetics, 2nd edn Wiley Liss: New York 1995
Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, Morgan E, Raimondi SC, Rowley JD, Gilliland DG . Fusion of the TEL gene on 12p13 to the AML1 on 21q22 in acute lymphoblastic leukemia Proc Natl Acad Sci USA 1995 92: 4917–4921
Romana SP, Mauchauffe M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA . The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion Blood 1995 85: 3662–3670
Romana SP, Poirel H, Le Coniat M, Flexor MA, Mauchauffe M, Jonveaux P, Macintyre EA, Berger R, Bernard OA . High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia Blood 1995 86: 4263–4269
Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan GC-F, Pui C-H, Grosveld G, Downing JR . TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis Leukemia 1995 9: 1985–1989
Schrock E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T . Multicolor spectral karyotyping of human chromosomes Science 1996 273: 494–497
Veldman T, Vignon C, Schrock E, Rowley JD, Ried T . Hidden chromosome abnormalities in hematological malignancies detected by multicolor spectral karyotyping Nat Genet 1997 15: 406–410
Rao PH, Cigudosa JC, Ning Y, Calasanz MJ, Iida S, Tagawa S, Michaeli J, Klein B, Dalla-Favera R, Jhanwar SC, Ried T, Chaganti RSK . Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma Blood 1998 92: 1743–1748
Sawyer JR, Lukacs JL, Munshi N, Desikan KR, Singhal S, Mehta J, Siegel D, Shaughnessy J, Barlogie B . Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping Blood 1998 92: 4269–4278
Kakazu N, Taniwaki M, Horiike S, Nishida K, Tatekawa T, Nagai M, Takahashi T, Akaogi T, Inazawa J, Ohki M, Abe T . Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome Genes Chromosom Cancer 1999 26: 336–345
Raimondi SC, Mathew S, Pui CH . Cytogenetics as a diagnostic aid for childhood hematological disorders. Conventional cytogenetic techniques, Fluorescence in situ hybridization and comparative genomic hybridization. In: Hanausek M, Walaszek Z, (eds) Methods in Molecular Medicine, Vol. 14. Tumor Marker Protocols Humana Press: Totowa 1998 pp 209–227
Mitelman F . An International System for Human Cytogenetic Nomenclature Karger: Basel 1995
Griffin CA, Hawkins AL, Henkle CT, Boone LB, Thomas GH, Stamberg J, Dvoark C, Heffner A . Cryptic translocations in myelodysplastic syndrome karyotypes are revealed by spectral karyotyping Am J Hum Genet 1998 63: 379a
Rowley JD, Reshmi S, Carlson K, Roulston D . Spectral karyotype analysis of T-cell acute leukemia Blood 1999 93: 2038–2042
Mitelman F . Catalog of Chromosome Aberrations in Cancer Wiley-Liss: New York 1998
Mitelman F, Heim S, Mandahl N . Trisomy 21 in neoplastic cells Am J Med Genet Suppl 1990 7: 62–66
Pui CH, Crist WM, Look AT . Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia Blood 1990 76: 1449–1463
Raimondi SC, Pui C-H, Head D, Behm F, Privitera E, Roberson PK, Gaston KR, Williams DL . Trisomy 21 as the sole acquired abnormality in children with acute lymphoblastic leukemia Leukemia 1992 6: 171–175
Liu Y, Soderhall S, Heyman M, Grander D, Brondum-Nielsen K, Einhorn S . Multiple genetic events involving RB1 gene deletion and amplification of chromosome 21 in a case of acute lymphoblastic leukemia Genes Chromosom Cancer 1994 9: 72–75
Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S . AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia Hematologica 2000 85: 362–366
Schrock E, Veldman T, Padilla-Nash H, Ning Y, Spurbeck J, Jalal S, Shaffer LG, Papenhausen P, Kozma C, Phelan MC, Kjeldsen E, Schonberg SA, O'Brien P, Biesecker L, du Manoir S, Ried T . Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities Hum Genet 1997 101: 255–262
Ning Y, Roschke A, Smith ACM, Macha M, Prescht K, Riethman H, Ledbetter D (Group 1), Flint J, Horsley S, Regan R, Kearney L, Knight S, Svaloy K, Brown WRA (Group 2) . A complete set of human telomeric probes and their clinical application. National Institutes of Health and Institute of Molecular Medicine collaboration Nat Genet 1996 14: 86–89
Acknowledgements
This work was supported in part by grant CA-20180 and Cancer Center Core grant CA-21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC). We thank Dr RSK Chaganti, Memorial Sloan-Kettering Cancer Center, for allowing us to use the Spectral Karyotyping system during the initial stages of the study. We also thank T O'Neill, P Mardis, E Entrekin, P Dalton, and R Marion for their assistance in the cytogenetic evaluations. We thank Dr JC Jones for editing the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mathew, S., Rao, P., Dalton, J. et al. Multicolor spectral karyotyping identifies novel translocations in childhood acute lymphoblastic leukemia. Leukemia 15, 468–472 (2001). https://doi.org/10.1038/sj.leu.2401989
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401989
Keywords
This article is cited by
-
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
Leukemia (2014)
-
Pediatric B-lymphoblastic leukemia with RUNX1 amplification: clinicopathologic study of eight cases
Modern Pathology (2011)
-
Molecular cytogenetics in haematological malignancy: current technology and future prospects
Chromosoma (2005)
-
The Runx genes: lineage-specific oncogenes and tumor suppressors
Oncogene (2004)
-
Molecular cytogenetics of polycythaemia vera: lack of occult rearrangements detectable by 20q LSP screening, CGH, and M-FISH
Leukemia (2003)